Fore Biotherapeutics: Valuation, Funding & Investors
Fore Biotherapeutics is a precision oncology company developing targeted cancer therapies for patients with unaddressed mutations across well-established oncology targets. The company pursues science-driven drug discovery and development to deliver therapies tailored to molecularly defined patient populations.
Leadership & Board
- Current Number of Employees
- 57
- Current LinkedIn Followers
- 5,051
Latest Estimated Valuation
- Total Amount Raised
- $67M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $67M
- Latest Funding Round
- Series D
Employee Trend
Fore Biotherapeutics had 57 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.
57Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Fore Biotherapeutics had 5,051 followers as of November 16, 2026. The number of followers increased by 14 (0.28%) week-over-week.
5,051Latest Followers Count
14(0.28%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jul 10, 2026 | Series D | $67.40M | ― |
Similar Companies
A snapshot of private companies similar to Fore Biotherapeutics, helping you discover and navigate related company profiles.
Related News and Analysis






